8-CPT-Cyclic AMP sodium
Modify Date: 2024-01-22 18:15:04
8-CPT-Cyclic AMP sodium structure
|
Common Name | 8-CPT-Cyclic AMP sodium | ||
|---|---|---|---|---|
| CAS Number | 93882-12-3 | Molecular Weight | 493.79 | |
| Density | N/A | Boiling Point | 799.2ºC at 760 mmHg | |
| Molecular Formula | C16H14ClN5NaO6PS | Melting Point | N/A | |
| MSDS | USA | Flash Point | 437.1ºC | |
Use of 8-CPT-Cyclic AMP sodium8-CPT-Cyclic AMP (8-CPT-cAMP) sodium is a selective activator of cyclic AMP-dependent protein kinase (PKA). 8-CPT-Cyclic AMP sodium is also a potent inhibitor of the cyclic GMP-specific phosphodiesterase (PDE VA) with an IC50 of 0.9 μM. 8-CPT-Cyclic AMP sodium also inhibits PDE III and PDE IV with IC50Epac and is a potent Epac activator[1][2]. |
| Name | sodium,(4aR,6R,7R,7aS)-6-[6-amino-8-(4-chlorophenyl)sulfanylpurin-9-yl]-2-oxido-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol |
|---|---|
| Synonym | More Synonyms |
| Description | 8-CPT-Cyclic AMP (8-CPT-cAMP) sodium is a selective activator of cyclic AMP-dependent protein kinase (PKA). 8-CPT-Cyclic AMP sodium is also a potent inhibitor of the cyclic GMP-specific phosphodiesterase (PDE VA) with an IC50 of 0.9 μM. 8-CPT-Cyclic AMP sodium also inhibits PDE III and PDE IV with IC50Epac and is a potent Epac activator[1][2]. |
|---|---|
| Related Catalog | |
| In Vitro | a-Fas and TNF-α/CHX induces neutrophil death rapidly (within 2 h) to at least 90%. The commonly used cAMP analog 8-pCPT-cAMP (0.7 mM) delays TNF- /CHX-induced and a-Fas-induced apoptosis. It is more efficient against apoptosis induced by TNF- /CHX than against a-Fas[2]. |
| References |
| Boiling Point | 799.2ºC at 760 mmHg |
|---|---|
| Molecular Formula | C16H14ClN5NaO6PS |
| Molecular Weight | 493.79 |
| Flash Point | 437.1ºC |
| Exact Mass | 492.998871 |
| PSA | 192.78000 |
| LogP | 3.00660 |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Nat. Chem. Biol. 3(5) , 268-273, (2007) The identification of self-renewing and multipotent neural stem cells (NSCs) in the mammalian brain holds promise for the treatment of neurological diseases and has yielded new insight into brain canc... |
|
|
Inhibition of glyceroneogenesis by histone deacetylase 3 contributes to lipodystrophy in mice with adipose tissue inflammation.
Endocrinology 152 , 1829-38, (2011) We have reported that the nuclear factor-κB (NF-κB) induces chronic inflammation in the adipose tissue of p65 transgenic (Tg) mice, in which the NF-κB subunit p65 (RelA) is overexpressed from the adip... |
|
|
p62/SQSTM1 upregulation constitutes a survival mechanism that occurs during granulocytic differentiation of acute myeloid leukemia cells.
Cell Death Differ. 21(12) , 1852-61, (2014) The p62/SQSTM1 adapter protein has an important role in the regulation of several key signaling pathways and helps transport ubiquitinated proteins to the autophagosomes and proteasome for degradation... |
| 8-(4-Chlorophenylthio)adenosine 3',5'-cyclic monophosphate sodium salt |
| pCPT-cAMP |
| MFCD00057683 |
| 4H-Furo[3,2-d]-1,3,2-dioxaphosphorin-7-ol, 6-[6-amino-8-[(4-chlorophenyl)thio]-9H-purin-9-yl]tetrahydro-2-hydroxy-, 2-oxide, sodium salt, (4aR,6R,7R,7aS)- (1:1) |
| EINECS 299-413-9 |
| Sodium (4aR,6R,7R,7aS)-6-{6-amino-8-[(4-chlorophenyl)sulfanyl]-9H-purin-9-yl}-7-hydroxytetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-2-olate 2-oxide |
| 8-CPT cAMP |